Sep 3 2009
LifeScience Alley® announced today that eight life science organizations from around the United States and Canada will be exhibiting cutting-edge technologies at the association’s Annual Conference on Dec. 9 as part of the New Technology Showcase. Three of the eight selected organizations will be presenting their technologies during the luncheon general session in front of an anticipated 1,600+ national and international life science professionals. The Annual Conference, being held at the Minneapolis Convention Center, features the New Technology Showcase with the objective of highlighting leading life science technologies that have the potential to greatly impact health care delivery.
AUM Cardiovascular of Minneapolis will be presenting a non-invasive, hand-held, fast, extremely affordable coronary artery disease assessment device; Exos Corporation of St. Paul, Minn., will be presenting a thermoformable lamination technology for external musculoskeletal stabilization and support; and VitalMedix, Inc. of Hudson, Wis., will be presenting a proprietary formulation to sustain trauma victims with severe blood loss until surgical intervention.
These organizations will be joined in the New Technology Showcase exhibit area, located in the heart of the exhibit hall, by the other five finalists: Access Genetics, an Eden Prairie, Minn., company exhibiting an integrated system of web-enabled molecular diagnostics, collaborative telemedicine, and materials management with turnkey support; Mespere Lifesciences, Inc. of Waterloo, Ontario exhibiting a non-invasive, hand-held, real-time venous visualization technology; Minnow Medical, Inc. a San Diego-based company exhibiting a non-ablative, energy-delivering balloon angioplasty to treat occlusive vascular; Nonin Medical of Plymouth, Minn., exhibiting a non-invasive, near-infrared spectroscopy (NIRS) measuring cerebral cortex blood oxygen saturation; and TransEndoscopic Surgical Technologies, Inc., a Minneapolis-based company exhibiting technologies for closure systems, anastomosis methods and sterile access devices for endoscopic surgical approach.
The New Technology Showcase, sponsored by Boston Scientific for the fourth consecutive year, provides an opportunity for companies around the world to send in applications to exhibit technologies representing medical devices, pharmaceuticals, biotechnology, and health care delivery. Steve Mertens, sr. vice president of research and development with the cardiovascular division at Boston Scientific, and current chair of the LifeScience Alley board of directors, asserts “Identifying and highlighting breakthrough technology is important to driving the life science industry. The New Technology showcase does just that by providing emerging and established companies an opportunity to introduce their most innovative products and therapies to other members of the life science community and key decision makers”.
Aptamer extends agreement with genetic medicines customer